News

BioLineRx Announces FDA Approval of Aphexda for Multiple Myeloma Treatment

1 Mins read

BioLineRx, a leading biopharmaceutical company, has received FDA approval for the use of Aphexda motixafortide in combination with filgrastim to mobilize stem cells for the treatment of patients with multiple myeloma.

What is Aphexda?

Aphexda is a groundbreaking medication that effectively mobilizes hematopoietic stem cells from the peripheral blood. These stem cells can then be collected and used for autologous transplantation, which has shown great promise in the treatment of multiple myeloma.

The Importance of Stem Cell Mobilization

Successful autologous stem cell transplantation requires adequate mobilization of stem cells during the treatment process. Aphexda has demonstrated its ability to effectively mobilize these vital cells, improving the outcomes for patients with multiple myeloma.

FDA Approval Based on Promising Results

The FDA’s approval of Aphexda was based on the compelling results of a comprehensive Phase 3 trial. This trial evaluated the safety and efficacy of Aphexda in combination with filgrastim, compared to a placebo with filgrastim.

Multiple Myeloma: A Persistent Challenge

Multiple myeloma is an aggressive and currently incurable blood cancer that primarily affects certain white blood cells. It is the second most common hematologic malignancy, posing significant challenges to healthcare providers and patients alike.

With the FDA approval of Aphexda, BioLineRx is set to make this innovative treatment available to patients later this month.

Related posts
News

Trump Media & Technology Group: Trump Media Reports First Quarter 2025 Results

4 Mins read
~ Ended First Quarter with $759.0 Million in Cash/Investments ~Trending NowBest Forex Trading Robots To Invest In 2022 ~ Operations Consumed Just…
News

Ethereum Explodes 25% Higher To $2,400, Notches Largest 1-Day Gain In 4 Years

1 Mins read
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.Trending NowBest Forex Trading Robots To…
News

FioBit's Ultimate Dogecoin Cloud Mining Guide for 2025: Secure DOGE Investment Without Hardware Using the Most Trusted Crypto Mining Provider to Hedge Against Bitcoin Drops | Business Upturn

2 Mins read
Sydney, Australia , May 08, 2025 (GLOBE NEWSWIRE) — As Bitcoin continues to experience short-term volatility in 2025, a growing number of…

Leave a Reply

Your email address will not be published. Required fields are marked *

− 7 = 1